At AAIC 2026, professor of neurology at Washington University in St. Louis discussed how integrating clinical assessment with amyloid biomarkers can improve diagnostic accuracy in Alzheimer disease. [WATCH TIME: 5 minutes]
Suzanne Schindler, MD, PhD
Advertisement
Professor of Neurology at Washington University in St. Louis.
Articles by Suzanne Schindler, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment
2
Phase 2 APPLAUDS Trial to Test Mivelsiran in Down Syndrome-Associated Alzheimer Disease
3
Inside the World's First Neural Stem Cell Trial for Huntington Disease
4
Baseline Tau Burden Linked to Reduced Amyloid Clearance With Gantenerumab in New GRADUATE Analysis
5